Skip to content

Technology Integrated Health Management (TIHM) for Dementia: a study of technologies in the home to monitor and manage the health of people with dementia

Technology Integrated Health Management (TIHM) for Dementia Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN46184518
Enrollment
1500
Registered
2018-10-10
Start date
2017-03-01
Completion date
Unknown
Last updated
2020-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia Mental and Behavioural Disorders

Interventions

Patients will be randomised 1:1 to either the TIHM for Dementia System of Care (Intervention arm) or standard care (control arm) Intervention arm: TIHM for Dementia System of Care – a

Sponsors

Surrey and Borders Partnership NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Person with dementia: 1. Aged over 50 years 2. Living at home in the community 3. Confirmed diagnosis of mild-to-moderate dementia made at least 3 months previously 4. Stable dementia - if on dementia medication had a stable dose for 3 months prior to recruitment 5. Baseline standard Mini–Mental State Examination (MMSE) score of greater than or equal to 14 6. A live-in or nominated carer providing at least 10 hours care per week Carer: 1. Aged 18 years or over 2. Nominated carer (by their relative/friend with dementia) who had known the person with dementia for at least 6 months 3. Able to attend research assessments with the person with dementia 4. Sufficient functional English to allow completion of the assessment instructions

Exclusion criteria

Exclusion criteria: Person with dementia: 1. In residential care 2. Unable to communicate verbally 3. Unable to provide informed consent 4. In receipt of any investigational drug within 30 days of consenting 5. Requiring regular elective hospital admission for monitoring of physical health 6. Receiving treatment for a terminal illness 7. Insufficient functional English to allow completion of assessment instructions 8. Unstable mental state including severe depression, severe psychosis, agitation and anxiety, requiring medication change over the previous 3 months 9. Severe sensory impairment 10. Active suicidal ideas Carers: 1. Insufficient functional English to allow completion of assessment instructions 2. Unstable mental state including severe depression, severe psychosis, agitation and anxiety, requiring medication change over the previous 3 month 3. Severe sensory impairment 4. Active suicidal ideas 5. Unable to communicate verbally 6. Unable to provide written informed consent

Design outcomes

Primary

MeasureTime frame
Hospitalisation as measured through carer self-reporting using the Client Service Receipt Inventory (CSRI) questionnaire taken at baseline, 3 months and 6 months.

Secondary

MeasureTime frame
1. Duration of hospital stay (carer self-report) 2. Time to admission to residential care (carer self-report) 3. Incidence and severity of neuropsychiatric symptoms experienced by the PwD assessed using the Neuropsychiatric Inventory (NPI) 4. Activities of daily living of the PwD assessed using the Bristol Activity of Daily Living Scale (BADL) 5. Health-related quality of life (HR-QoL) of the PwD assessed using Dementia Quality of Life Measure (DEMQOL), DEMQOL-proxy and EQ-5D-5L questionnaires 6. HR-QoL of carers assessed using EQ-5D-5L and Adult Carer Quality of Life questionnaires 7. Carer burden assessed using the Zarit Caregiver burden scale 8. Technology acceptance assessed using the Technology Acceptance Model Measure (TAM) 9. Attitudes towards technology assessed using Global Attitude Towards Technology Measure: Technophobia All measures taken at baseline, 3 months and 6 months.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026